| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |